Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy

Study ID: NCT05115760
Start Date: 2022-04-05
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Dietary Supplement

Quality-of-Life Assessment

Administration questionnaire

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Study ID: NCT05625360
Start Date: 2023-06-13
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

160

Intervention / Treatment

eHealth Mindful Movement and Breathing

Life Impacts Reflection

Promised questionnaires

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Glioblastoma Remote Monitoring and Care - Research Protocol

Study ID: NCT06129760
Start Date: 2024-04-30
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Apple Watch

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Tremelimumb + Durvalumab (Med4736) + Belinostat and Urothelial Carcinoma

Study ID: NCT05154994
Start Date: 2022-01-14
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

9

Intervention / Treatment

Whiteness

Durvalumab

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Study ID: NCT05789394
Start Date: 2023-06-16
End Date: 2025-07-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Allogeneic Adipose-derived Mesenchymal Stem Cells

Biospecimen Collection

Craniotomy

Magnetic Resonance Imaging

Ommaya Reservoir Tap

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

Study ID: NCT04421560
Start Date: 2020-08-01
End Date: 2026-01-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

37

Intervention / Treatment

Ibrutinib

Pembrolizumab

Rituximab

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Pre-malignant States to Hematologic Malignancies in Firefighters

Study ID: NCT06870760
Start Date: 2025-06
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Monoclonal Gammopathy

Complete Blood Count with differential (CBC w/ diff)

Clonal hematopoiesis (CHIP)

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy

Study ID: NCT05815160
Start Date: 2023-05-02
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

78

Intervention / Treatment

Debio 0123

Etoposide

Carboplatin

Sponsor

Debiopharm International SA

Source: clinicaltrials.gov

Share:
Add to list

Safety and Durability of Sirolimus for Treatment of LAM

Study ID: NCT02432560
Start Date: 2015-03
End Date: 2025-07-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Sirolimus

Everolimus

Sponsor

University of Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

Study ID: NCT05448560
Start Date: 2023-01-01
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Multi-level Intervention of shared model of survivorship care

Comparison Group

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list